“The ratings reflect our view of such factors as UCHealth’s significant market presence, excellent historical profitability and cash flow resulting in solid pro forma maximum annual debt service coverage and operational liquidity that provides significant cushion,” said S&P analyst Brian Williamson.
The ratings agency also affirmed the ratings on UCHA’s following bonds:
- “AA-” long-term rating on its series 2012A bonds
- “AA-” long-term rating on its series 2012B bonds
- “AA-” long-term rating on its series 2017A bonds
- “AA-” long-term rating on its series 2017C-1 bonds
- “AA-” long-term rating on its series 2017C-2 bonds
S&P also affirmed the “AA-” rating on UCHA’s series 2005A, 2005B and 2005C bonds issued for Fort Collins, Colo.-based Poudre Valley Health System.
The outlook is stable, reflecting S&P’s expectation UCHA’s financial results will most likely remain strong and its balance sheet metrics will improve.
More articles on healthcare finance:
Moody’s revises St. John Health System’s outlook to negative
Moody’s downgrades Capital Region Medical Center’s rating to ‘Baa1’
Moody’s revises Tampa Bay General Hospital’s outlook to stable
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.